Singapore, April 8 -- Japan's Meiji Seika Pharma has announced that its local subsidiary, Meiji Pharma Asia has commenced operations in Singapore on April 1,2026. This subsidiary is intended to strengthen Meiji Seika Pharma's presence and expand its business in the ASEAN region through the commercialisation, marketing and distribution of pharmaceuticals, including vaccines.

Meiji Seika Pharma aims to become "a leading company in Asia in the field of infectious diseases" as part of the "Meiji Group 2026 Vision" targeting 2026. Leveraging nearly half a century of experience in manufacturing and marketing pharmaceuticals in Thailand and Indonesia, Meiji Seika Pharma will position Singapore as a hub for its business and commercial strat...